GENE ONLINE|News &
Opinion
Blog

Novartis
Trials & Approvals CAR-T therapyCAR T-cell Therapy
FDA Boxed Warning for CAR-T therapy, Affecting Bristol-Myers Squibb, Novartis, Janssen, Gilead Sciences
2024-01-24
JPM 2024 Global EventsDrug Price NegotiationDigital Healthcare
JPM 2024: More Noteworthy Industry Stories and Updates of Long-rumored Cytokinetics Acquisition
2024-01-15
JPM 2024 JPMJP Morgan 2024
JPM 2024: GSK Buys Aiolos Bio for $1.4 Billion, Cytokinetics Acquisition Sparks Three-way Contest
2024-01-10
Asia-Pacific partnershipBiosimilar
Novartis’ Generic-drugs Unit Partners with Samsung Bioepis for Biosimilar Drug Launch
2023-09-12
Feature FDA ApprovalGene and Cell Therapy
GeneOnline’s Weekly News Highlights: July 31-Aug 4
2023-08-07
M&A Neuromuscular Disorder
Novartis Acquires DTx Pharma and Expands Its Neuroscience Pipeline
2023-07-20
Special biomedicalHealthcare
GeneOnline’s Weekly News Highlights: June 12-16
2023-06-17
M&A acquisitionNovartis
Novartis Plans to Acquire Chinook Therapeutics in a Potential $3.5B Deal, Revolutionizing IgAN Treatment Landscape
2023-06-14
Partnerships Novartis
Novartis Lays Down $40 Million for 3BP’s FAP-Targeting Oncology Tech
2023-04-24
Trials & Approvals Breast Cancer
Novartis’ CDK4/6 Inhibitor Meets Phase 3 Endpoints In Breast Cancer
2023-03-28
Trials & Approvals brain cancer
Novartis Snags Pediatric Brain Cancer Indication for Oncology Combination Therapy
2023-03-19
Regulatory Gene Therapy
EMA Plans to Issue Liver Failure Warning for Novartis’ Gene Therapy
2023-01-16
Special JPM
JPM23: More Deals as JP Morgan Healthcare Conference 2023 Enters the Third Day
2023-01-12
Special Healthcare Industry
GeneOnline’s Pick: Top 10 Industry News Stories in 2022
2022-12-26
Licensing Clovis Oncology
Clovis Offloads Cancer Candidate to Novartis, Day After Declaring Bankruptcy
2022-12-13
1 2 3 … 7
LATEST
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top